CoChat

Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats

Okada, Yoshihisa, Yamaguchi, Kanji, Nakajima, Tomoki, Nishikawa, Taichiro, Jo, Masayasu, Mitsumoto, Yasuhide, Kimura, Hiroyuki, Nishimura, Takeshi, Tochiki, Nozomi, Yasui, Kohichiroh, Mitsuyoshi, Hironori, Minami, Masahito, Kagawa, Keizo, Okanoue, Takeshi, Itoh, Yoshito · 2013 · Liver International
Cited by 61

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background/Aims: Statins, which are inhibitors of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase and inhibit endogenous cholesterol synthesis, possess pleiotropic activities, such as anti‐inflammatory, anti‐oxidative and antifibrotic effects. Here, we investigated whether statins ameliorate steatohepatitis using a high‐fat and high‐cholesterol (HFHC) diet‐induced rat model. Methods: Eight‐week‐old male Sprague–Dawley rats were fed control chow or HFHC diet. Half of the HFHC diet‐fed rats were orally administered 2 mg/kg/day rosuvastatin for 12 weeks. Hepatic injury, steatosis, fibrosis and markers of lipid peroxidation/oxidant stress were evaluated. Results: As previously reported, HFHC diet induced steatohepatitis in rat livers with hypercholesterolaemia. Rosuvastatin decreased Oil Red O stained‐positive areas, liver/body weight ratio, serum total cholesterol levels and hepatic free fatty acid contents in HFHC diet‐fed rats. Further study revealed that rosuvastatin significantly decreased hepatic mRNA expression of tumour necrosis factor‐α and interleukin‐6, serum alanine aminotransferase levels and hepatic lobular inflammation grade. Hepatic fibrosis was also ameliorated by rosuvastatin with decreases in hepatic mRNA expression of transforming growth factor‐β, connective tissue growth factor and type‐1 procollagen. Similarly, hepatic Sirius red stained or α‐smooth muscle actin stained‐positive areas and expression of markers of lipid peroxidation/oxidant stress [hepatic 8‐hydroxy‐oxyguanosine and hepatic 4‐hydroxy‐2‐nonenal] were decreased. Interestingly, whereas the expression of carnitine palmitoyltransferase‐1 and long‐chain acyl‐CoA dehydrogenase was not affected, that of catalase and acyl‐coA oxidase was restored. Conclusions: These data suggest that rosuvastatin improved not only hepatic steatosis but also hepatic injury and fibrosis via improved peroxisomal β‐oxidation in this rat HFHC model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.12033

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 61

Metadata

Authors
Okada, Y., Yamaguchi, K., Nakajima, T., Nishikawa, T., Jo, M., Mitsumoto, Y., Kimura, H., Nishimura, T., Tochiki, N., Yasui, K., Mitsuyoshi, H., Minami, M., Kagawa, K., Okanoue, T., & Itoh, Y.
Venue
Liver International
Publisher
Wiley
Published
2013-01-07
Volume
33
Issue
2
Pages
301-311
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2043338651
Cited by
61
References
4
FWCI
2.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats. https://app.cochat.ai/papers/10.1111/liv.12033
The paper
Okada, Y., Yamaguchi, K., Nakajima, T., Nishikawa, T., Jo, M., Mitsumoto, Y., Kimura, H., Nishimura, T., Tochiki, N., Yasui, K., Mitsuyoshi, H., Minami, M., Kagawa, K., Okanoue, T., & Itoh, Y. (2013). Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats. Liver International. https://doi.org/10.1111/liv.12033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.